期刊文献+

163例外周T细胞淋巴瘤-非特指型患者的临床特征及预后分析 被引量:7

Clinical Characteristics and Treatment Response of 163 Patients with Peripheral T-cell Lymphoma Unspecified
下载PDF
导出
摘要 目的:阐明中国人群中外周T细胞淋巴瘤-非特指型(PTCL-U)患者的临床特征,并探讨其与预后的关系。方法:回顾性分析2002年1月~2006年12月期间收治的初治PTCL-U患者163例,分析其临床特征,采用卡方检验(Chi-square test),比较不同临床特征与完全缓解率之间的关系。结果:PTCL-U患者的中位年龄39岁;男女比例为2.4:1;74.85%的患者有结外侵犯,最常见的结外侵犯部位是咽淋巴环(鼻咽、扁桃体和软腭);完全缓解率43.56%;Ⅲ~Ⅳ期、乳酸脱氢酶高、出现结外侵犯、体能状况差、巨大包块者完全缓解率低;性别、年龄、B症状及是否放疗与完全缓解率无显著性相关;国际预后指数(IPI)不同的患者,其完全缓解率有显著性差异。结论:中国人群中PTCL-U常发生于年轻男性患者,大部分患者伴有结外侵犯,完全缓解率低,可以利用IPI指数预测其疗效与预后。 Objective:To analyze the clinical characteristics and treatment response of 163 cases with peripheral T-cell lymphoma unspecified(PTCL-U)and to explore the association between its clinical characteristics and prognosis.Methods:163 cases with PTCL-U treated between January 2002 and December 2006 in Guangxi Cancer Hospital were retrospectively analyzed.The association between clinical features and the probability of attaining complete remission(CR)was evaluated by Chi-square test.Results:The median age of patients was 39 years,and the male-to-female ratio was 2.4:1.The extranodal involvement rate was 74.85% and Waldeyer's ring was the most frequent site.The CR rate was 43.56% and the factors associated with a lower probability of achieving CR were advanced disease(stage Ⅲ-Ⅳ),the presence of extranodal involvement,poor performance status(PS),high LDH levels,bulky disease and International Prognostic Index(IPI).Conclusion:There is a preponderance of males and a low CR rate in cases with PTCL-U.IPI is shown to be of highly significant prognostic value.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2007年第17期982-985,共4页 Chinese Journal of Clinical Oncology
关键词 外周 T细胞淋巴瘤 临床特征 预后 Peripheral T Cell lymphoma Clinical characteristics Prognosis
  • 相关文献

参考文献10

  • 1Rudiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma (excluding anaplasdc large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project [J].Ann Oncol, 2002, 13(1): 140-149
  • 2Savage KJ, Chhanabhai M, Gascoyne RD, et al. Characterization of peripheral T-cell lymphomas iu a single North American institution by the WHO classification [J]. Ann Oncol, 2004, 15 (10): 1467 - 1475
  • 3彭玉龙,黄慧强,周中梅,林旭滨,潘战和,管忠震.外周T细胞淋巴瘤-非特异型(PTCL-U)117例长期临床随访结果分析[J].中国癌症杂志,2006,16(2):132-135. 被引量:14
  • 4Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified ( PTCL-U): a new prognostic model from a retrospective multicentric clinical study [J]. Blood, 2004, 103 (7): 2474-2479
  • 5黄慧强,彭玉龙,林旭滨,孙晓菲,林桐榆,夏忠军,李宇红,蔡清清,何友兼,姜文奇,管忠震.CHOP方案治疗106例外周T细胞淋巴瘤的临床长期随访结果分析[J].癌症,2004,23(z1):1443-1447. 被引量:25
  • 6张玉晶,任忠敏,吴秋良,何振宇,黄岩,夏云飞,林桐榆,崔念基.112例鼻和鼻咽外周T细胞淋巴瘤患者的疗效和预后分析[J].中华血液学杂志,2006,27(4):217-221. 被引量:8
  • 7Rodriguez J, Munsell M, Yazji S, et al. Impact of high-dose chemotherapy on peripheral T-cell Iymphomas [J]. J Clin Oncol, 2001, 19(17): 3766-3770
  • 8Rodriguez J, Caballero MD, Gutierrez A, et al. High-dose chemotherapy and autologous stem cell transplantation in peripheral T-cell lymphoma: the GEL-TAMO experience[J]. Ann Oncol, 2003, 14(12): 1768-1775
  • 9Mounier N, Gisselbrecht C, Briere J, et al. All aggressive lymphoma subtypes do not share similar outcome after front-line autotransplantation: a matched-control analysis by the Groupe d'Etude des Lymphomes de l'Adulte (GELA) [J].Ann Oncol, 2004,15(12): 1790-1797
  • 10Mounier N, Gisselbrecht C, Briere J, et al. Prognostic factors in patients with aggressive non-Hodgkin's lymphoma treated by front-line autotransplantation after complete remission: a cohort study by the Groupe d'Etude des Lymphomes de l'Adulte [J]. J Clin Oncol,2004,22 (14): 2826-2834

二级参考文献37

  • 1[1]Kim K, Kim WS, Jung CW, et al. Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the REAL classification [J]. Eur J Cancer, 2002, 38 (1): 75 - 81.
  • 2[2]Edward R, Arrowsmit H, William R, et al. Peripheral T-cell Lymphomas: clinical features and prognostic factors of 92 cases defined by the Revised European American lymphoma classification [J]. Leuk Lymphoma, 2003, 44(2) :241 - 249.
  • 3[3]Gallamini A, Stelitano C, Calvi R, et al. Peripheral T-cell lymphoma unspecified(PTCL-U): a new prognostic model from a retrospective multicentric clinical study [J] . Blood, 2004, 103(7): 2474 - 2479.
  • 4[4]Rudiger T, Weisenburger DD, Anderson JR, et al. Peripheral T-cell lymphoma(excluding anaplastic large-cell lymphoma):results from the Non-Hodgkin's Lymphoma classification project [J].Ann Oncol, 2002, 13 ( 1 ): 140 - 149.
  • 5[5]Lee HK, Wilder RB, Jones D, et al. Outcomes using doxorubicin-based chemotherapy with or without radiotherapy for early-stage peripheral T-cell lymphomas [J]. Leu Lymphoma,2002, 43(9): 1769 - 1775.
  • 6[6]Pellatt J, Sweetenham J, Pickering RM, et al. A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma [J]. Ann Hematol, 2002, 81 (5):267 - 272.
  • 7[7]Lopez-Guillermo A, Cid J, Salar A, et al. Peripheral T-cell lymphoma: initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the REAL Classification [J]. Ann Oncol, 1998, 9(8): 849 - 855.
  • 8[8]Harris NL, Jaffe ES, Stein H, et al. A revised European-American classfication of Lmphoid neoplasms: a proposal from the international lymphoma study group [J]. Blood, 1994, 84(5):1361 - 1392.
  • 9[9]Zaja F, Russo D, Silvestri F, et al. Retrospective analysis of 23cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome [J]. Hematologica, 1997, 82(2):171 - 177.
  • 10[10]Liang R, Todd D, Chan TK, Chiu E, et al. Intensive chemotherapy for peripheral T-cell lymphomas. Hematol Oncol, 1992, 10(3 -4): 155 - 161.

共引文献42

同被引文献137

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部